Literature DB >> 22034518

Human breast cancer histoid: an in vitro 3-dimensional co-culture model that mimics breast cancer tissue.

Pavinder Kaur1, Brenda Ward, Baisakhi Saha, Lillian Young, Susan Groshen, Geza Techy, Yani Lu, Roscoe Atkinson, Clive R Taylor, Marylou Ingram, S Ashraf Imam.   

Abstract

Progress in our understanding of heterotypic cellular interaction in the tumor microenvironment, which is recognized to play major roles in cancer progression, has been hampered due to unavailability of an appropriate in vitro co-culture model. The aim of this study was to generate an in vitro 3-dimensional human breast cancer model, which consists of cancer cells and fibroblasts. Breast cancer cells (UACC-893) and fibroblasts at various densities were co-cultured in a rotating suspension culture system to establish co-culture parameters. Subsequently, UACC-893, BT.20, or MDA.MB.453 were co-cultured with fibroblasts for 9 days. Co-cultures resulted in the generation of breast cancer histoid (BCH) with cancer cells showing the invasion of fibroblast spheroids, which were visualized by immunohistochemical (IHC) staining of sections (4 µm thick) of BCH. A reproducible quantitative expression of C-erbB.2 was detected in UACC-893 cancer cells in BCH sections by IHC staining and the Automated Cellular Imaging System. BCH sections also consistently exhibited qualitative expression of pancytokeratins, p53, Ki-67, or E-cadherin in cancer cells and that of vimentin or GSTPi in fibroblasts, fibronectin in the basement membrane and collagen IV in the extracellular matrix. The expression of the protein analytes and cellular architecture of BCH were markedly similar to those of breast cancer tissue.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22034518      PMCID: PMC3283087          DOI: 10.1369/0022155411423680

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  37 in total

1.  Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression.

Authors:  M P Shekhar; J Werdell; S J Santner; R J Pauley; L Tait
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

Review 2.  Exploring the tumour environment: cancer-associated fibroblasts as targets in cancer therapy.

Authors:  Patrick Micke; Arne Ostman
Journal:  Expert Opin Ther Targets       Date:  2005-12       Impact factor: 6.902

3.  Cancer-associated myofibroblasts possess various factors to promote endometrial tumor progression.

Authors:  A Orimo; Y Tomioka; Y Shimizu; M Sato; S Oigawa; K Kamata; Y Nogi; S Inoue; M Takahashi; T Hata; M Muramatsu
Journal:  Clin Cancer Res       Date:  2001-10       Impact factor: 12.531

4.  Three-dimensional fibroblast-tumor cell interaction causes downregulation of RACK1 mRNA expression in breast cancer cells in vitro.

Authors:  Paula Seidl; Robert Huettinger; Ruth Knuechel; Leoni A Kunz-Schughart
Journal:  Int J Cancer       Date:  2002-11-10       Impact factor: 7.396

5.  Transition to invasion in breast cancer: a microfluidic in vitro model enables examination of spatial and temporal effects.

Authors:  Kyung Eun Sung; Ning Yang; Carolyn Pehlke; Patricia J Keely; Kevin W Eliceiri; Andreas Friedl; David J Beebe
Journal:  Integr Biol (Camb)       Date:  2010-12-07       Impact factor: 2.192

6.  Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells.

Authors:  Mirco Galiè; Carlo Sorrentino; Maura Montani; Luigi Micossi; Emma Di Carlo; Tommaso D'Antuono; Laura Calderan; Pasquina Marzola; Donatella Benati; Flavia Merigo; Fiorenza Orlando; Arianna Smorlesi; Cristina Marchini; Augusto Amici; Andrea Sbarbati
Journal:  Carcinogenesis       Date:  2005-06-23       Impact factor: 4.944

7.  Gene expression profiling reveals cross-talk between melanoma and fibroblasts: implications for host-tumor interactions in metastasis.

Authors:  Paul G Gallagher; Yongde Bao; Alyson Prorock; Paola Zigrino; Roswitha Nischt; Vincenzo Politi; Cornelia Mauch; Bojan Dragulev; Jay William Fox
Journal:  Cancer Res       Date:  2005-05-15       Impact factor: 12.701

8.  To create the correct microenvironment: three-dimensional heterotypic collagen assays for human breast epithelial morphogenesis and neoplasia.

Authors:  Thorarinn Gudjonsson; Lone Rønnov-Jessen; René Villadsen; Mina J Bissell; Ole William Petersen
Journal:  Methods       Date:  2003-07       Impact factor: 3.608

9.  Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition.

Authors:  Thorarinn Gudjonsson; Lone Rønnov-Jessen; René Villadsen; Fritz Rank; Mina J Bissell; Ole William Petersen
Journal:  J Cell Sci       Date:  2002-01-01       Impact factor: 5.285

10.  Permanent phenotypic and genotypic changes of prostate cancer cells cultured in a three-dimensional rotating-wall vessel.

Authors:  H W Rhee; H E Zhau; S Pathak; A S Multani; S Pennanen; T Visakorpi; L W Chung
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-03       Impact factor: 2.723

View more
  13 in total

Review 1.  The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer.

Authors:  Britta Weigelt; Cyrus M Ghajar; Mina J Bissell
Journal:  Adv Drug Deliv Rev       Date:  2014-01-09       Impact factor: 15.470

2.  Three-dimensional cell culture: A powerful tool in tumor research and drug discovery.

Authors:  Donglai Lv; Zongtao Hu; Lin Lu; Husheng Lu; Xiuli Xu
Journal:  Oncol Lett       Date:  2017-10-03       Impact factor: 2.967

Review 3.  Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy.

Authors:  Geeta Mehta; Amy Y Hsiao; Marylou Ingram; Gary D Luker; Shuichi Takayama
Journal:  J Control Release       Date:  2012-05-18       Impact factor: 9.776

Review 4.  Three-dimensional in vitro tumor models for cancer research and drug evaluation.

Authors:  Xian Xu; Mary C Farach-Carson; Xinqiao Jia
Journal:  Biotechnol Adv       Date:  2014-08-10       Impact factor: 14.227

5.  Standardization of negative controls in diagnostic immunohistochemistry: recommendations from the international ad hoc expert panel.

Authors:  Emina E Torlakovic; Glenn Francis; John Garratt; Blake Gilks; Elizabeth Hyjek; Merdol Ibrahim; Rodney Miller; Søren Nielsen; Eugen B Petcu; Paul E Swanson; Clive R Taylor; Mogens Vyberg
Journal:  Appl Immunohistochem Mol Morphol       Date:  2014-04

Review 6.  Advances in the formation, use and understanding of multi-cellular spheroids.

Authors:  Toni-Marie Achilli; Julia Meyer; Jeffrey R Morgan
Journal:  Expert Opin Biol Ther       Date:  2012-07-12       Impact factor: 4.388

Review 7.  Using space-based investigations to inform cancer research on Earth.

Authors:  Jeanne L Becker; Glauco R Souza
Journal:  Nat Rev Cancer       Date:  2013-04-12       Impact factor: 60.716

8.  Breast Cancer Reconstruction: Design Criteria for a Humanized Microphysiological System.

Authors:  Trivia Frazier; Christopher Williams; Michael Henderson; Tamika Duplessis; Emma Rogers; Xiying Wu; Katie Hamel; Elizabeth C Martin; Omair Mohiuddin; Shahensha Shaik; Ram Devireddy; Brian G Rowan; Daniel J Hayes; Jeffrey M Gimble
Journal:  Tissue Eng Part A       Date:  2021-03-10       Impact factor: 3.845

9.  Bioreactor-Based Tumor Tissue Engineering.

Authors:  A E Guller; P N Grebenyuk; A B Shekhter; A V Zvyagin; S M Deyev
Journal:  Acta Naturae       Date:  2016 Jul-Sep       Impact factor: 1.845

10.  Evaluation of Extracellular Matrix Composition to Improve Breast Cancer Modeling.

Authors:  Charles Ethan Byrne; Jean-Baptiste Decombe; Grace C Bingham; Jordan Remont; Lindsay G Miller; Layah Khalif; Connor T King; Katie Hamel; Bruce A Bunnell; Matthew E Burow; Elizabeth C Martin
Journal:  Tissue Eng Part A       Date:  2021-04       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.